Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD
Author:
Funder
BI
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference31 articles.
1. Use of Respimat soft mist inhaler in COPD patients;Anderson;Int J Chron Obstruct Pulmon Dis,2006
2. Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary disease;Balkrishnan;Clin Ther,2000
3. A one-year trial of tiotropium Respimat plus usual therapy in COPD patients;Bateman;Respir Med,2010
4. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD);Cecere;COPD,2012
5. COPD as a lung disease with systemic consequences–clinical impact, mechanisms, and potential for early intervention;Decramer;COPD,2008
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tiotropium in chronic obstructive pulmonary disease – a review of clinical development;Respiratory Research;2020-07-29
2. Optimizing bronchodilation in the prevention of COPD exacerbations;Respiratory Research;2017-06-20
3. Tiotropium formulations and safety: a network meta-analysis;Therapeutic Advances in Drug Safety;2016-09-16
4. Effect of tiotropium on COPD exacerbations: A systematic review;Respiratory Medicine;2016-05
5. Relationship Between FEV1 and Patient-Reported Outcomes Changes: Results of a Meta-Analysis of Randomized Trials in Stable COPD;Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3